VANI
Vivani Medical, Inc. Common Stock (DE)
Nasdaq · usd
Vivani Medical, Inc. Common Stock (DE) (VANI) trades at $1.05 (+2.94%) as of 7:30:01 PM EST on Nov 17, 2026, -6.25% over the past month. Market cap is $92.01M, with 2.0 days to cover in short interest.
Stock performance
How Vivani Medical, Inc. Common Stock (DE) (VANI) stock has performed from one day to one year, with its 52-week range.
- 1D
- +2.94%
- 1W
- -8.70%
- 1M
- -6.25%
- YTD
- -14.63%
- 1Y
- -25.53%
- 52-wk range
- $0.80 – $1.66
Key statistics
Today's trading snapshot for VANI: day range, open, previous close, volume and market cap.
- Day range
- $0.99 – $1.09
- Open
- $1.02
- Prev close
- $1.02
- Volume
- 260.15K
- Market cap
- $92.01M
- Shares out
- 90.2M
Valuation and profitability ratios: P/E, P/S, ROE
Valuation and profitability ratios for Vivani Medical, Inc. Common Stock (DE): P/E, P/S, P/B, ROE and more.
- P/E
- —
- P/S
- —
- P/B
- 6.96
- P/FCF
- —
- ROE
- -204.5%
- ROA
- -76.6%
- Debt/Equity
- 0.00
- Div yield
- 0.00%
As of Nov 16, 2026
8-K filings
Material corporate events Vivani Medical, Inc. Common Stock (DE) has disclosed to the SEC on Form 8-K.
- Clinical trial resultsNov 12, 2026
The pharmacokinetic results showed no rapid increases in drug exposure with NPM-139, with maximum semaglutide levels following a single administration measured at approximately 16 days, compared with approximately 2.4 days following the first weekly Wegovy injection. Over the four-week trial, observed weight loss was 0.79% in the NPM-139 group and 0.82% in the Wegovy group.
- Merger agreementOct 30, 2026
Vivani Medical, Inc. ("Vivani") entered into a definitive agreement and plan of merger among its wholly owned subsidiary Cortigent, Inc. ("Cortigent"), ClearOne, Inc. ("ClearOne"), and CLRO Merger Sub, Inc. ("MergerSub"), pursuant to which Cortigent will merge with and into MergerSub and become a wholly owned subsidiary of ClearOne (the "Transaction").
- Investor presentationOct 29, 2026
Vivani Medical, Inc. ("Vivani") from time to time presents, and/or distributes to the investment community at various industry and other conferences, slide presentations to provide updates and summaries of its business. A copy of these slides is attached to this Current Report on Form 8-K as Exhibit 99.1.
- Merger agreementSep 16, 2026
As previously disclosed, Vivani Medical, Inc. ("Vivani") entered into a definitive agreement and plan of merger among its wholly owned subsidiary Cortigent, Inc. ("Cortigent"), ClearOne, Inc. ("ClearOne"), and CLRO Merger Sub, Inc. ("MergerSub"), pursuant to which Cortigent will merge with and into MergerSub and become a wholly owned subsidiary of ClearOne (the "Transaction").
- Investor presentationAug 17, 2026
Vivani Medical, Inc. ("Vivani") from time to time presents, and/or distributes to the investment community at various industry and other conferences, slide presentations to provide updates and summaries of its business. A copy of these slides is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated by reference herein.
Dividend history and stock splits
Vivani Medical, Inc. Common Stock (DE)'s recent dividend payments and stock splits.
Dividends
No recent dividends.
Splits
- 1-for-3Aug 19, 2022
- 1-for-8Jan 6, 2020
VANI short interest
How heavily VANI is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 2.0
- Short interest
- 369.79K
- Avg volume
- 181.96K
As of · reported to FINRA twice monthly.
VANI news
The latest news and headlines about Vivani Medical, Inc. Common Stock (DE) (VANI).
- Has Novo Nordisk Finally Found the Catalyst That Could Flip the Script on Eli Lilly?positiveThe Motley Fool· Aug 29, 2026
- Presenting on Emerging Growth Conference 94 Day 1 on July 15; Register to live streamneutralGlobeNewswire Inc.· Jul 14, 2026
- Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.positiveGlobeNewswire Inc.· Jul 2, 2026
- Vivani Medical, Inc. Announces Pricing of Common Stock OfferingneutralGlobeNewswire Inc.· Jan 25, 2026
- Vivani Medical, Inc. Announces Pricing of Common Stock OfferingneutralGlobeNewswire Inc.· Oct 26, 2025
Frequently asked questions
What is the Vivani Medical, Inc. Common Stock (DE) (VANI) stock price today?
Vivani Medical, Inc. Common Stock (DE) (VANI) is trading at $1.05 (+2.94% on the day) as of 7:30:01 PM EST on Nov 17, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is Vivani Medical, Inc. Common Stock (DE)?
Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery…
What is the short interest in VANI?
As of Oct 30, 2026, VANI has 369.79K shares short and 2.0 days to cover.
What exchange is VANI listed on?
Vivani Medical, Inc. Common Stock (DE) (VANI) trades on Nasdaq in USD, in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS industry.
Build with AI
Build an analysis of VANI with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a VANI analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.